Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greatest decrease » treatment decreased (Expand Search), greater increase (Expand Search)
less decrease » mean decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
Showing 2,021 - 2,040 results of 21,342 for search '(( significant decrease decrease ) OR ( significantly ((less decrease) OR (greatest decrease)) ))', query time: 0.44s Refine Results
  1. 2021
    Metformin and ZLN005 attenuate MAC-mediated mitochondrial membrane potential damage.

    Metformin and ZLN005 attenuate MAC-mediated mitochondrial membrane potential damage. by Joel R. Frandsen (20685133)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 2022
    Metformin and ZLN005 facilitate increased phagocytic uptake and intracellular killing of MAB.

    Metformin and ZLN005 facilitate increased phagocytic uptake and intracellular killing of MAB. by Joel R. Frandsen (20685133)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 2023
    NTM infection induces mitochondrial damage and reduces mitochondria number.

    NTM infection induces mitochondrial damage and reduces mitochondria number. by Joel R. Frandsen (20685133)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 2024
    Exploring Metalloproteome Remodeling in Calprotectin-Stressed Acinetobacter baumannii Using Chemoproteomics

    Exploring Metalloproteome Remodeling in Calprotectin-Stressed Acinetobacter baumannii Using Chemoproteomics by Maximillian K. Osterberg (22514185)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 2025
    Age-specific incidence trends of HFMD in Guangzhou from 2013 to 2023.

    Age-specific incidence trends of HFMD in Guangzhou from 2013 to 2023. by Haipeng Luo (5322419)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 2026
    Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during letrozole treatment.

    Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during letrozole treatment. by Kazuyoshi Ohkawa (836847)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  7. 2027
    Average proportion of first choice female applicants stratified by specialty category.

    Average proportion of first choice female applicants stratified by specialty category. by Lucy Hui (17538542)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 2028
    Temporal Trends and Forecasting of Hand, Foot, and Mouth Disease.

    Temporal Trends and Forecasting of Hand, Foot, and Mouth Disease. by Haipeng Luo (5322419)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 2029
    Gender-specific incidence trends of HFMD in Guangzhou from 2013 to 2023.

    Gender-specific incidence trends of HFMD in Guangzhou from 2013 to 2023. by Haipeng Luo (5322419)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 2030
    Temporal distribution of HFMD incidence in Guangzhou from 2013 to 2023.

    Temporal distribution of HFMD incidence in Guangzhou from 2013 to 2023. by Haipeng Luo (5322419)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 2031
    Flowchart of patient selection in this study.

    Flowchart of patient selection in this study. by Kazuyoshi Ohkawa (836847)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  12. 2032
    Changes in the FIB-4 index in breast cancer patients with a FIB-4 index of ≥ 2.67 during letrozole and anastrozole treatment.

    Changes in the FIB-4 index in breast cancer patients with a FIB-4 index of ≥ 2.67 during letrozole and anastrozole treatment. by Kazuyoshi Ohkawa (836847)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  13. 2033
    Age-specific and gender-specific incidence trends of HFMD in Guangzhou, 2013–2023.

    Age-specific and gender-specific incidence trends of HFMD in Guangzhou, 2013–2023. by Haipeng Luo (5322419)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 2034
    Exploring Metalloproteome Remodeling in Calprotectin-Stressed Acinetobacter baumannii Using Chemoproteomics

    Exploring Metalloproteome Remodeling in Calprotectin-Stressed Acinetobacter baumannii Using Chemoproteomics by Maximillian K. Osterberg (22514185)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 2035
    Gender differences in first choice match outcomes.

    Gender differences in first choice match outcomes. by Lucy Hui (17538542)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 2036
    Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during anastrozole treatment.

    Changes in the liver fibrosis-related markers in breast cancer patients with a FIB-4 index of >2.30 during anastrozole treatment. by Kazuyoshi Ohkawa (836847)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  17. 2037
    Clinical features and cancer treatment in patients with breast cancer receiving letrozole and anastrozole.

    Clinical features and cancer treatment in patients with breast cancer receiving letrozole and anastrozole. by Kazuyoshi Ohkawa (836847)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  18. 2038
    Exploring Metalloproteome Remodeling in Calprotectin-Stressed Acinetobacter baumannii Using Chemoproteomics

    Exploring Metalloproteome Remodeling in Calprotectin-Stressed Acinetobacter baumannii Using Chemoproteomics by Maximillian K. Osterberg (22514185)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 2039
    S1 Data -

    S1 Data - by Kazuyoshi Ohkawa (836847)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  20. 2040
    Clinical course of patient no.

    Clinical course of patient no. by Kazuyoshi Ohkawa (836847)

    Published 2024
    Subjects:
    Save to List
    Saved in:

Search Tools: